Business & Finance
Citius Pharmaceuticals reports full-year financial results
24 December 2025 - Late-stage biopharmaceutical company Citius Pharmaceuticals Inc (Nasdaq:CTXR) announced on Tuesday its financial results for the fiscal year ended 30 September 2025.Citius Pharma di...
Sanofi receives FDA complete response letter for tolebrutinib in progressive MS
24 December 2025 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) said on Wednesday that the US Food and Drug Administration (FDA) has issued a complete response letter for th...
Abbott announces quarterly common dividend increase
15 December 2025 - Abbott (NYSE: ABT), a global healthcare company, on Friday announced its quarterly common dividend.The company has declared a dividend of USD0.63 per share, up 6.8% compared to the ...
Amgen announces Q1 2026 dividend
10 December 2025 - Biopharmaceutical company Amgen (NASDAQ:AMGN) on Tuesday announced a dividend of USD2.52 per share for the first quarter of 2026.This is an increase from the USD2.38 per share paid ...
Eli Lilly announces Q1 2026 dividend
9 December 2025 - Pharmaceutical company Eli Lilly and Company (NYSE:LLY) announced on Monday a dividend of USD1.73 per share on outstanding common stock for the first quarter of 2026.This is an incre...
Oxford Nanopore and bioMérieux introduce AmPORE-TB for rapid tuberculosis resistance characterisation
5 November 2025 - French diagnostics company bioMérieux (Euronext Paris:BIM) and UK-based molecular sensing technology company Oxford Nanopore Technologies (LON:ONT) on Wednesday announced the ...